Aprea Therapeutics, Inc. (APRE)

NASDAQ: APRE · Real-Time Price · USD

1.450

+0.030 (2.11%)

At close: Oct 29, 2025, 4:00 PM EDT

1.440

-0.010 (-0.69%)

After-hours: Oct 29, 2025, 7:26 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Novel Synthetic Lethality-based Cancer Therapeutics	1.50M	Log In
Novel Synthetic Lethality-based Cancer Therapeutics Growth	157.63%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.